Search

everythinglearnresearchcommunity

for

Search:↓

The congress showed that psychological therapy can help skin condition patients, social media affects acne stigma, education improves atopic dermatitis, and patient satisfaction in dermatology is high, especially with good doctor engagement.

Hair loss can significantly affect mental health.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

Skin symptoms without a medical cause often reflect psychological stress and are influenced by culture, requiring a team approach for treatment.

Trichodynia is a painful scalp condition linked to hair loss and mental health issues, with limited treatment options.

People with an imbalance between their cognitive and emotional empathy have lower levels of the hormone oxytocin in their hair.

Alopecia areata often starts around age 23, can be permanent in 30% of cases, and treatments are usually temporary.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

Drugs for hormone-related conditions might help treat mental disorders but could have serious side effects.

The document concludes that transsexual individuals often experience improved quality of life after transitioning, despite higher risks of psychiatric issues and mortality.

Neurosteroids can influence behavior by modulating brain inhibition, with potential for treating psychiatric disorders.

Asylum seekers arriving by boat may face skin problems due to harsh conditions, and doctors should use a thorough skin assessment approach to diagnose and treat them effectively.

Women with PCOS have a higher chance of experiencing depression, anxiety, and sleep disorders.

Skin doctors should recognize and treat conditions like hair-pulling and skin-picking early, often using therapy and medication, to help 50-70% of patients.

Doctors should consider psychological factors when treating skin conditions and work with mental health experts.

Mindfulness reduces anxiety and depression in skin disease patients; dermatologists and psychiatrists often lack confidence in treating psychodermatological conditions.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Psychiatric symptoms can be early signs of systemic lupus erythematosus.

Onabotulinumtoxin-A effectively treated a painful scalp condition when other treatments failed.

COVID-19 can cause rashes and worsen existing skin conditions, and behaviors like frequent hand-washing can lead to hand dermatitis.

Accurate diagnosis and tailored treatment are crucial for managing common primary care symptoms.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Patients with schizophrenia have a high rate of skin diseases, with fungal infections and dermatitis being most common, and those on clozapine have a lower risk of fungal infections.

The new classification system for skin disorders emphasizes the importance of understanding a patient's awareness of their condition for better treatment.

A man wrongly believed he had parasites, showing that delusional infestation can affect men and is often linked with other psychiatric issues, but can be treated with antipsychotics.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Erectile dysfunction is increasingly common in men under 40, with many physical and psychological causes, and various treatment options available.

Antidepressants may improve or resolve scalp dysesthesia in most patients.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.